Jiajie Xu

Jiajie Xu


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Materials Today Bio
Verified
Journal Article
Open access
CSChengying Shao
Chengying Shao
ZLZhenfang Li
Zhenfang Li
CZChengchi Zhang
Chengchi Zhang
WZWanchen Zhang
Wanchen Zhang
RHRu He
Ru He
YCYu Cai
Yu Cai
Thyroid cancer, as one of the most common endocrine cancers, has seen a surge in incidence in recent years. This is most likely due to the lack of specificity and accuracy of its traditional diagnostic modalities, leading to the overdiagnosis of thyroid nodules. Although there are several treatment options available, they are limited to surgery and 131I radiation therapy that come with significant side effects and hence cannot meet the treatment needs of anaplastic thyroid carcinoma with very high malignancy. Optical imaging that utilizes optical absorption, refraction and scattering properties, not only observes the structure and function of cells, tissues, organs, or even the whole organism to assist in diagnosis, but can also be used to perform optical therapy to achieve targeted non-invasive and precise treatment of thyroid cancer. These applications of screening, diagnosis, and treatment, lend to optical imaging's promising potential within the realm of thyroid cancer surgical navigation. Over the past decade, research on optical imaging in the diagnosis and treatment of thyroid cancer has been growing year by year, but no comprehensive review on this topic has been published. Here, we review key advances in the application of optical imaging in the diagnosis and treatment of thyroid cancer and discuss the challenges and potential for clinical translation of this technology.

27 January 2024 in Clinical and Translational Medicine
Verified
Journal Article
Open access
XRXinxin Ren
Xinxin Ren
XWXiang Wang
Xiang Wang
GZGuowan Zheng
Guowan Zheng
SWShanshan Wang
Shanshan Wang
QWQiyue Wang
Qiyue Wang
MGMinghua Ge
Minghua Ge
Background: One‐carbon (1C) metabolism is a metabolic network that plays essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to fuel metabolic pathways, including nucleotide metabolism, amino acid metabolism, cellular redox defence and epigenetic maintenance. At present, 1C metabolism is considered the hallmark of cancer. The 1C units obtained from the metabolic pathways increase the proliferation rate of cancer cells. In addition, anticancer drugs, such as methotrexate, which target 1C metabolism, have long been used in the clinic. In terms of immunotherapy, 1C metabolism has been used to explore biomarkers connected with immunotherapy response and immune‐related adverse events in patients.Methods: We collected numerous literatures to explain the roles of one‐carbon metabolism in cancer immunotherapy.Results: In this review, we focus on the important pathways in 1C metabolism and the function of 1C metabolism enzymes in cancer immunotherapy. Then, we summarise the inhibitors acting on 1C metabolism and their potential application on cancer immunotherapy. Finally, we provide a viewpoint and conclusion regarding the opportunities and challenges of targeting 1C metabolism for cancer immunotherapy in clinical practicability in the future.Conclusion: Targeting one‐carbon metabolism is useful for cancer immunotherapy.

1 October 2014 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
HWHuanhuan Wu
Huanhuan Wu
LYLiya Yang
Liya Yang
SLShuyuan Li
Shuyuan Li
XJXiaolei Jin
Xiaolei Jin
JXJiajie Xu
Jiajie Xu
LTLi Teng
Li Teng

24 December 2024 in Neoplasia
Verified
Journal Article
Open access
YZYining Zhang
Yining Zhang
ZLZhenfang Li
Zhenfang Li
CZChengchi Zhang
Chengchi Zhang
CSChengying Shao
Chengying Shao
YDYanting Duan
Yanting Duan
JXJiajie Xu
Jiajie Xu
Head and neck squamous cell carcinoma (HNSCC) are the most common type of head and neck tumor that severely threatens human health due to its highly aggressive nature and susceptibility to distant metastasis. The diagnosis of HNSCC currently relies on biopsy and histopathological examination of suspicious lesions. However, the early mucosal changes are subtle and difficult to detect by conventional oral examination. As for treatment, surgery is still the primary treatment modality. Due to the complex anatomy and the lack of intraoperative modalities to accurately determine the incision margins, surgeons are in a dilemma between extensive tumor removal and improving the quality of patient survival. As more knowledge is gained about HNSCC, the increasing recognition of the value of optical imaging has been emphasized. Optical technology offers distinctive possibilities for early preoperative diagnosis, intraoperative real-time visualization of tumor margins, sentinel lymph node biopsies, phototherapy. Fluorescence imaging, narrow-band imaging, Raman spectroscopy, optical coherence tomography, hyperspectral imaging, and photoacoustic imaging have been reported for imaging HNSCC. This article provides a comprehensive overview of the fundamental principles and clinical applications of optical imaging in the diagnosis and treatment of HNSCC, focusing on identifying its strengths and limitations to facilitate advancements in this field.

7 July 2023 in Head & Neck
Verified
Journal Article
Open access
DLDong‐Ning Lu
Dong‐Ning Lu
WZWan‐Chen Zhang
Wan‐Chen Zhang
YLYan‐Ze Lin
Yan‐Ze Lin
YZYi‐Ning Zhang
Yi‐Ning Zhang
CSCheng‐Ying Shao
Cheng‐Ying Shao
JXJiajie Xu
Jiajie Xu
Background: This paper aims to analyze the time trend of OCs incidence in 43 countries (1988–2012) and predict the incidence trend of OCs (2012–2030).Methods: In the database for Cancer Incidence in Five Continents, the annual data on OCs incidence grouped by age and gender were obtained from 108 cancer registries in 43 countries. The age‐standardized incidence rates were calculated, and the Bayesian age‐period‐cohort model was used to predict the incidence in 2030.Results: South Asia and Oceania had the highest ASR in 1988 (9.24/100 000) and 2012 (6.74/100 000). It was predicted that India, Thailand, the United Kingdom, the Czech Republic, Austria, and Japan would be the countries with an increased incidence of OCs in 2030.Conclusion: Regional custom is an important factor affecting the incidence of OCs. According to our predictions., it is necessary to control risk factors according to local conditions and enhance screening and education.

1 August 2005 in Journal of Urology
Verified
Journal Article
Closed access
QLQiang Li
Qiang Li
SLSenkai Li
Senkai Li
WCWen Chen
Wen Chen
JXJiajie Xu
Jiajie Xu
MYMing Yong Yang
Ming Yong Yang
ZZZhenmin Zhao
Zhenmin Zhao
Purpose: Hypospadias is one of the most common congenital deformities in the male urogenital system. Although there are more than 250 techniques for treating hypospadias, it is often difficult to repair severe hypospadias using conventional methods. Materials and Methods: We combined a buccal mucosa graft with a local onlay flap for urethral reconstruction in cases of severe hypospadias or a failed previous operation. A total of 162 patients with hypospadias (glandular 11, penile 40, penoscrotal 49, scrotal 34 and perineal 28) were treated between July 2000 and November 2003. For patients whose urethral meatus was perineal 2 treatment steps were taken. First, we used the aforementioned method to construct the penile urethra, and then we constructed the scrotal and perineal urethra with a local flap. Results: Of the 134 nonperineal cases 127 were managed successfully in 1 stage, and 26 of 28 perineal cases were managed successfully in 2 stages. Most patients had a satisfactory penile appearance. A urethral fistula resulted in 8 cases, of which 4 closed spontaneously within 1 month postoperatively. Meatal stenosis occurred in 1 case. Conclusions: This technique is simple, safe and reliable, especially in cases of failed previous operation or for salvage hypospadias repair with deficient local tissue.